Ashton Thomas Private Wealth LLC Buys 2,712 Shares of McKesson Corporation $MCK

Key Points

• Ashton Thomas Private Wealth LLC boosted its stake in McKesson by 50.0% in Q4, buying 2,712 shares to hold 8,133 shares worth about $6.678 million at period end.
• Institutional investors own 85.07% of McKesson; analysts carry a consensus "Moderate Buy" with an average price target of $972.27, and the company recently beat quarterly EPS and set FY2026 guidance of 38.800–39.200 EPS.

Ashton Thomas Private Wealth LLC boosted its stake in shares of McKesson Corporation (NYSE:MCK - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,133 shares of the company's stock after purchasing an additional 2,712 shares during the period. Ashton Thomas Private Wealth LLC's holdings in McKesson were worth $6,678,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in McKesson by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 12,104,719 shares of the company's stock valued at $9,929,380,000 after buying an additional 73,109 shares during the last quarter. State Street Corp increased its holdings in McKesson by 0.9% during the third quarter. State Street Corp now owns 5,750,519 shares of the company's stock valued at $4,447,110,000 after buying an additional 51,510 shares during the last quarter. Franklin Resources Inc. increased its holdings in McKesson by 3.5% during the third quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock valued at $2,071,428,000 after buying an additional 90,948 shares during the last quarter. Alliancebernstein L.P. increased its holdings in McKesson by 5.6% during the third quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock valued at $1,850,001,000 after buying an additional 126,684 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in McKesson by 0.4% during the third quarter. Northern Trust Corp now owns 1,532,856 shares of the company's stock valued at $1,184,193,000 after buying an additional 6,613 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

Analysts Set New Price Targets

MCK has been the subject of a number of research reports. TD Cowen upped their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a report on Thursday, February 5th. Evercore reaffirmed an "outperform" rating on shares of McKesson in a report on Thursday, March 5th. Morgan Stanley reaffirmed an "overweight" rating and set a $966.00 target price on shares of McKesson in a report on Thursday, January 29th. Leerink Partners reaffirmed an "outperform" rating and set a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. Finally, Wells Fargo & Company upped their target price on shares of McKesson from $914.00 to $925.00 and gave the company an "equal weight" rating in a report on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $972.27.

Insider Activity

In related news, EVP Leann B. Smith sold 190 shares of the firm's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the transaction, the executive vice president directly owned 2,989 shares of the company's stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 3,592 shares of company stock valued at $3,518,555. 0.08% of the stock is currently owned by company insiders.

McKesson Price Performance

Shares of NYSE MCK opened at $828.16 on Tuesday. The firm has a fifty day moving average price of $902.00 and a 200-day moving average price of $859.23. The stock has a market cap of $101.44 billion, a PE ratio of 23.82, a price-to-earnings-growth ratio of 1.19 and a beta of 0.42. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts expect that McKesson Corporation will post 39.02 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson's dividend payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.